Abstract:BACKGROUND:Ferroferric oxide (Fe3O4) nanoparticles are a research hotspot in drug delivery system, which can transport antineoplastic drugs to the lesion under external magnetic field. Additional y, its submicrons even can reach the tumor site several centimeters far away from the magnetic source. OBJECTIVE:To investigate the histocompatibility and in vivo distribution of Fe3O4 nanoparticles and to explore its application prospect and limitations as a drug carrier in the chemotherapy of osteosarcoma. METHODS:10.0 mg/kg Fe3O4 nanoparticles were administrated into Wistar rats via tail vein, then the rats were executed at 15, 60 and 120 minutes, respectively, and the rat lung, brain, heart, liver, kidney, hind limb and skeletal muscle were removed. The ferric ion content in each tissue was determined by atomic absorption spectrometer, and the morphological changes of different tissues were observed by hematoxylin-eosin staining at each time point. RESULTS AND CONCLUSION:After administrated for 15 minutes, the concentration of Fe3O4 nanoparticles in the liver and kidney reached peak, fol owed by a decrease at 60 and 120 minutes, but stil remained a high level. The concentration of Fe3O4 nanoparticles at three time points showed significant difference compared with the control group (P<0.05), demonstrating that the nanoparticles can be quickly enriched and long-term persistent in the liver and kidney. After administrated for 15 minutes, the concentration of Fe3O4 nanoparticles in the heart, lung, skeletal muscle and bone reached peak, which had significant difference compared with the control group (P<0.05), and significantly decreased subsequently except that in the bone. This significant difference stil displayed at 60 minutes between groups (P<0.05), indicating that the nanoparticle can reach a high concentration but persist short time in the high blood perfused tissues. Compared with the control group, the concentration of Fe3O4 nanoparticles in the brain tissue showed no significant difference at each time point (P>0.05), suggesting that the blood-brain barrier can inhibit the nanoparticle penetration. No overt morphological changes were found in each tissue after hematoxylin-eosin staining. In conclusion, the distribution of Fe3O4 nanoparticles conjugate sodium oleate in organism is influenced by the blood perfusion and mononuclear phagocyte system, and they cannot penetrate the blood-brain barrier and make no significant effect on tissues, but maintain a high level in the liver kidney and bone for a long-term, thus providing a theoretical basis for the drug delivery system in the magenetic hyperthermia therapy of malignant tumors.

Study On Pharmacokinetics Of Fe(2)O(3) Nanoparticles Coated With Glutamic Acid In Mice

The Pharmacokinetics Study of Nanoparticles of Fe2O3 Coated with Glutamic Acid

Determing the biodistribution of nano-Fe2O3-Glu in mice by 59Fe tracer and preparation

Pharmacokinetic parameters and tissue distribution of magnetic Fe3O4 nanoparticles in mice

Studies on Toxicity and Mutagenicity of Nanoparticles of Fe3O4 and Fe3O4 Coated with Glutamic Acid

Study on Pharmacokinetics and Acute Toxicology Magnetic of Magnetic Fe3O4 Nanoparticles

THE IN VIVO INVESTIGATION OF Fe3O4-NANOPARTICLES ACUTE TOXICITY IN MICE

Biodistribution and Acute Toxicity of Intravenous Multifunctional 125I-Radiolabeled Fe3O4-Ag Heterodimer Nanoparticles in Mice

Preparation of magnetic Fe3O4 nanoparticles and its influence on the viscera of ICR mice

Tissue Distribution and Excretion of Intravenously Administered Titanium Dioxide Nanoparticles

Particokinetics and Extrapulmonary Translocation of Intratracheally Instilled Ferric Oxide Nanoparticles in Rats and the Potential Health Risk Assessment.

Combined toxicity of Fe3 O4 nanoparticles and cadmium chloride in the liver of mice by oral route

Subchronic Toxicity Study of Ferric Oxide Nanoparticles Through Intragastric Administration: A 94-D, Repeated Dose Study in Sprague Dawley Rats

Comparative Study of Pulmonary Responses to Nano- and Submicron-Sized Ferric Oxide in Rats.

Histocompatibility and distribution of ferroferric oxide nanoparticles

Evaluation on Cytotoxicity and Genotoxicity of the L-glutamic Acid Coated Iron Oxide Nanoparticles.

Distribution of Amphotericin B Loaded Polylactic Acid-polyethylene Glycol Nanoparticles in Mice

Effects of Core Size and PEG Coating Layer of Iron Oxide Nanoparticles on the Distribution and Metabolism in Mice

Pharmacokinetics of Chitosan-Polyaspartic Acid-5-fluorouracil Nanoparticles in Mice

Preparation of Magnetoliposomes and Its in Vivo Behavior on ICR Mice

Study on Pharmacokinetics of Emodin Solid Lipid Nanoparticles in Rats